Aug 07, 2026

Novartis Malaysia’s Living Well, Living Longer Breast Cancer Survivorship Ecosystem Recognized Across 4 Regional Industry Platforms 

Novartis LWLL
  • Living Well, Living Longer (LWLL) recognized across Healthcare Asia Pharma Awards, PR Awards Southeast Asia, PRCA APAC Awards and Content Marketing Awards Asia-Pacific
  • Integrated survivorship ecosystem recognized for advancing patient advocacy, education and psychosocial support for women living with breast cancer.

Petaling Jaya, 07 August 2026 – Novartis Malaysia's Living Well, Living Longer (LWLL), an integrated breast cancer survivorship ecosystem, has been recognized across four leading regional industry award platforms in 2026 for its innovative approach to supporting women beyond diagnosis and treatment.

Developed in collaboration with clinicians, patient advocacy groups and breast cancer survivors, LWLL brings together three complementary initiatives: the Living Well, Living Longer Coffee Table Book, the ICanCare app and Gift of Time patient workshops. Together, they provide trusted information, patient navigation and psychosocial support through a connected survivorship ecosystem designed for Malaysian women. 

LWLL was developed in response to the growing need for more coordinated survivorship support in Malaysia, where many women continue to face challenges accessing reliable information and psychosocial care after treatment. By connecting educational resources, digital support and community engagement within a single ecosystem, the program complements clinical care and helps women navigate life with greater confidence.

Since its launch, the initiative has recorded more than 6,000 ICanCare app downloads, achieved over 50% active user engagement, contributed to a 250% increase in demand for psychosocial support, and driven a 133% year on year increase in Gift of Time workshop bookings, demonstrating growing demand for coordinated survivorship support. [1]

Sanjeev Balachandran, Country President of Novartis Malaysia, Brunei and Asia Emerging Markets (AEM), said:

"A breast cancer diagnosis changes far more than a patient's treatment plan. Many women continue to navigate emotional, practical, and informational challenges long after treatment ends. Living Well, Living Longer was created to ensure they have access to trusted guidance and support throughout that experience.

We are honored that this work has been recognized across several regional award platforms. More importantly, it reinforces the importance of long-term collaboration between healthcare professionals, patient advocacy groups and industry to strengthen survivorship support for women living with breast cancer, helping improve and extend patients’ lives."

The recognition spans patient advocacy, healthcare communications and purpose-driven storytelling across four regional award programs.

Healthcare Asia Pharma Awards 2026 [2]

  • Marketing & Communications Initiative of the Year - Malaysia
  • Patient Advocacy Program of the Year - Malaysia

 

Marketing-Interactive PR Awards Southeast Asia 2026 [3]

  • Silver: Best Event-Led PR Campaign 
  • Silver: PR Team of the Year (Brand) 

  • Bronze: Best PR Campaign: Healthcare & Pharmaceuticals

     

PRCA APAC Awards 2026 [4]

  • Game Changer Award 

     

Content Marketing Awards Asia Pacific 2026 [5]

  • Gold: Best Content Campaign for Advocacy & Community Building
  • Silver: Best Content Campaign in Healthcare & Pharmaceuticals 
  • Bronze: Best Purpose-Driven Content Campaign 

 

To learn more about Novartis Malaysia and its work in reimagining medicine, together, visit https://www.novartis.com/my-en/. 

- END -

About Novartis Malaysia

Novartis Malaysia has a long heritage and legacy in the country. Established in 1971, Novartis Malaysia is a leading multinational company with over 600 employees across the Novartis International division and the Novartis Corporate Center Kuala Lumpur (NOCC KL), which delivers enterprise and regional services to 24 countries including Novartis headquarters in Basel. Through its over 50-year presence in Malaysia, Novartis Malaysia continues to deliver on its corporate purpose of reimagining medicine to improve and extend the lives of over 35 million Malaysians.

In 2022, Novartis Malaysia was recognized as Sponsor of the Year by Clinical Research Malaysia for initiating 24 new clinical trials and has built a strong track record of expanding access to innovative medicines through collaborations with the Ministry of Health—touching the lives of more than 1.7 million Malaysian patients.

Most recently, Novartis Malaysia earned the Great Place to Work® (GPTW®) Certification for 2025/2026, with 85% of employees affirming it as a great place to work—reflecting a workplace culture grounded in trust, flexibility, inclusion, and purpose driven careers. Novartis Malaysia is also recognized as one of Malaysia’s top ten Best Workplaces in 2026, underscoring the organization’s commitment to creating an environment where associates feel supported, valued, and empowered to thrive.

Reference:

[1] Data on file
[2] Healthcare Asia Pharma Awards – Past Winners (2026)
[3] Marketing-Interactive PR Awards 2026 – 2026 Winners
[4] PRCA APAC Awards 2026 – 2026 Award Winners
[5] Marketech APAC Content Marketing Awards Asia Pacific 2026 - Winners